Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-29

Clinical Trial Update: The Ondansetron Premedication Trial in Juvenile Idiopathic Arthritis [NA]

View source ↗

Summary

A clinical trial evaluated ondansetron as a premedication for Juvenile Idiopathic Arthritis and it is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

Sponsor: University of British Columbia | Conditions: Juvenile Idiopathic Arthritis | NA | Status: COMPLETED